UConn Health Center HomeCenter for Molecular Medicine
HOME NEWS EMPLOYMENT MAPS & DIRECTIONS HELPFUL LINKS CONTACT US
 
 

Anne Delany Ph.D.

Anne Delany Ph.D.Investigator, Center for Molecular Medicine
Assistant Professor of Medicine

Email: adelany@uchc.edu
Phone: 860-679-8730
Fax: 860-679-7639

Research Interests

  • Function and Regulation of Osteonectin/SPARC in Bone
  • Regulation of Osteoblast Gene Expression by MicroRNAs
  • Bone Matrix-mediated Regulation of Gene Expression in Prostate Cancer Cells  

We are interested in understanding how components of the bone matrix regulate the behavior of normal bone cells and metastatic cancer cells.  Our work focuses on the matricellular glycoprotein osteonectin or SPARC.  It is the most abundant non-collagenous matrix component of the bone and it can modulate cell behavior as well as play an organizational role in the matrix.  Osteonectin is widely expressed in areas of active remodeling and cellular stress in multiple organ systems.  We found that osteonectin is critical for the maintenance of bone mass, and for the appropriate response of the skeleton to bone-anabolic PTH therapy. 

Further, we found that 3 SNPs (single nucleotide polymorphisms) in the 3’ untranslated region (UTR) of osteonectin are associated with bone mass in a subset of osteoporosis patients.  Our in vitro studies indicate that these SNPs can differentially regulate gene expression.  Our present studies are focused on understanding how these SNPs regulate gene expression in vitro and in vivo, using a knock-in mouse strategy.  In addition, we found that a specific family of microRNAs (miRNAs) acts as negative regulators of osteonectin expression in osteoblasts.  We are characterizing the mechanisms regulating the expression of these miRNAs in bone cells, and determining other genes that may also be regulated by these miRNAs.   
Lastly, we are interested in understanding how bone matrix composition and organization impacts the growth and survival of prostate carcinoma cells in the skeleton.  Bone-metastatic prostate carcinoma cells often create an “osteoblastic response”, resulting in the deposition of a disorganized bone matrix.  We will determine whether this matrix can preferentially support cancer cell survival.  Our research makes use of novel in vitro and in vivo models. 

Lab Rotation Projects:
Students with their own questions on how the extracellular matrix modules cell function are welcome.  Projects already available in the lab include:

  • Determine how SNPs in the osteonectin 3’ UTR modulate gene expression in vivo, by analyzing the   skeletal phenotype of 3’ UTR is knock-in mice.
  • Determine the mechanisms regulating the miR-29 family in osteoblasts.
  • Identify other miR-29 targets in osteoblasts and osteoclasts.
  • Determine the impact of bone matrix organization on the behavior and survival of metastatic prostate carcinoma cells. 
  
A-Z INDEX        UCONN HEALTH CENTER        TEXT-ONLY © University of Connecticut Health Center
Disclaimer   Privacy Notice
Maps & Directions